Synthesis and biological evaluation of PET tracers designed for imaging of calcium acti-vated potassium channel 3.1 (KCa3.1) channels in vivo.

Brömmel, K., Konken, C.P. (shared first authorship), Börgel, F., Obeng-Darko, H., Schel-haas, S., Bulk, E., Budde, T., Schwab, A., Schäfers, M., Wünsch, B. (2021)
In: RSC Advances, 11
Art der Publikation: Forschungsartikel (Zeitschrift)

Combined PET imaging of the inflammatory tumor microenvironment identifies margins of unique radiotracer uptake.

Zinnhardt B, Pigeon H, Thézé B, Viel T, Wachsmuth L, Fricke IB, Schelhaas S, Honold L, Schwegmann K, Wagner S, Faust A, Faber C, Kuhlmann MT, Hermann S, Schäfers M, Winkeler A, Jacobs AH. (2017)
In: Cancer Research, 77(8)
Art der Publikation: Forschungsartikel (Zeitschrift)

The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models.

Heinzmann K, Honess D, Lewis D, Smith D, Cawthorne C, Keen H, Heskamp S, Schelhaas S, Witney T, Soloviev D, Williams K, Jacobs A, Aboagye E, Griffiths J, Brindle K. (2016)
In: EJNMMI Research, 6(1)
Art der Publikation: Forschungsartikel (Zeitschrift)

Gemcitabine mechanism of action confounds early assessment of treatment response by 3′-Deoxy-3′-[18F]fluorothymidine in preclinical models of lung cancer.

Schelhaas S, Held A, Wachsmuth L, Hermann S, Honess D, Heinzmann K, Smith D, Griffiths J, Faber C, Jacobs A. (2016)
In: Cancer Research, 76(24)
Art der Publikation: Forschungsartikel (Zeitschrift)

Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer

Bäumer S., Bäumer N., Appel N., Terheyden L., Fremerey J., Schelhaas S., Wardelmann E., Buchholz F., Berdel W., Müller-Tidow C. (2015)
In: Clinical Cancer Research, 21(6)
Art der Publikation: Forschungsartikel (Zeitschrift)

Publikationen

Kontakt

Top-Links

Synthesis and biological evaluation of PET tracers designed for imaging of calcium acti-vated potassium channel 3.1 (KCa3.1) channels in vivo. Brömmel, K., Konken, C.P. (shared first authorship), Börgel, F., Obeng-Darko, H., Schel-haas, S., Bulk, E., Budde, T., Schwab, A., Schäfers, M., Wünsch, B. (2021) In: RSC Advances, 11 Art der Publikation: Forschungsartikel (Zeitschrift)
Prophylactic Antiviral Activity of Sulfated Glycomimetic Oligomers and Polymers Soria-Martinez, Laura; Bauer, Sebastian; Giesler, Markus; Schelhaas, Sonja; Materlik, Jennifer; Janus, Kevin; Pierzyna, Patrick; Becker, Miriam; Snyder, Nicole L.; Hartmann, Laura; Schelhaas, Mario (2020) In: Journal of the American Chemical Society, 142(11) Art der Publikation: Forschungsartikel (Zeitschrift)
Combined PET imaging of the inflammatory tumor microenvironment identifies margins of unique radiotracer uptake. Zinnhardt B, Pigeon H, Thézé B, Viel T, Wachsmuth L, Fricke IB, Schelhaas S, Honold L, Schwegmann K, Wagner S, Faust A, Faber C, Kuhlmann MT, Hermann S, Schäfers M, Winkeler A, Jacobs AH. (2017) In: Cancer Research, 77(8) Art der Publikation: Forschungsartikel (Zeitschrift)
In vivo bioluminescence imaging of neurogenesis - the role of the blood brain barrier in an experimental model of Parkinson's disease. Fricke IB, Schelhaas S, Zinnhardt B, Viel T, Hermann S, Couillard-Després S, Jacobs AH. (2017) In: Eur J Neurosci., ejn.13540 Art der Publikation: Forschungsartikel (Zeitschrift)
The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models. Heinzmann K, Honess D, Lewis D, Smith D, Cawthorne C, Keen H, Heskamp S, Schelhaas S, Witney T, Soloviev D, Williams K, Jacobs A, Aboagye E, Griffiths J, Brindle K. (2016) In: EJNMMI Research, 6(1) Art der Publikation: Forschungsartikel (Zeitschrift)
Preclinical evidence that 3′-deoxy-3′-[18F]fluorothymidine PET can visualize recovery of hematopoiesis after gemcitabine chemotherapy. Schelhaas S, Held A, Bäumer N, Viel T, Hermann S, Müller-Tidow C, Jacobs A. (2016) In: Cancer Research, 76(24) Art der Publikation: Forschungsartikel (Zeitschrift)
Gemcitabine mechanism of action confounds early assessment of treatment response by 3′-Deoxy-3′-[18F]fluorothymidine in preclinical models of lung cancer. Schelhaas S, Held A, Wachsmuth L, Hermann S, Honess D, Heinzmann K, Smith D, Griffiths J, Faber C, Jacobs A. (2016) In: Cancer Research, 76(24) Art der Publikation: Forschungsartikel (Zeitschrift)
PEGylated human serum albumin (HSA) nanoparticles: Preparation, characterization and quantification of the PEGylation extent. Fahrländer E., Schelhaas S., Jacobs A., Langer K. (2015) In: Nanotechnology, 26(14) Art der Publikation: Forschungsartikel (Zeitschrift)
Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer Bäumer S., Bäumer N., Appel N., Terheyden L., Fremerey J., Schelhaas S., Wardelmann E., Buchholz F., Berdel W., Müller-Tidow C. (2015) In: Clinical Cancer Research, 21(6) Art der Publikation: Forschungsartikel (Zeitschrift)
Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer. Bulk E, Ay A, Hammadi M, Ouadid-Ahidouch H, Schelhaas S, Hascher A, Rohde C, Thoennissen NH, Wiewrodt R, Schmidt E, Marra A, Hillejan L, Jacobs AH, Klein H, Dugas M, Berdel WE, Muller-Tidow C, Schwab A (2015) In: International Journal of Cancer, 137(6) Art der Publikation: Forschungsartikel (Zeitschrift)